Results
75,427 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Curran TerrieDirector |  ARQTArcutis Biotherapeutics, Inc.Option exercise | M | $233K 27.1K sh | Aug 28, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Curran TerrieDirector | ARQTArcutis Biotherapeutics, Inc. Option exercise | M | $233K 27.1K sh | Aug 28, 2026 |
| 24 | Shefman RandySVP & General Counsel |  RGLDROYAL GOLD INCOpen-market sale | SELL | $131K 500 sh | Aug 28, 2026 traded Aug 28, 2026 |
| 24 | Hodulik Andrew GDirector |  MGYRMagyar Bancorp, Inc.Grant or award | A | — 19.6K sh | Aug 28, 2026 traded Aug 26, 2022 |
| 24 | Kyte Cecil BondDirector, Chief Executive Officer |  QSEPQS Energy, Inc.Grant or award | A | — 166.7K sh | Aug 28, 2026 traded Jan 1, 2026 |
| 23 | Bunting EricDirector | QSEPQS Energy, Inc. Derivative conversion | C | $15K 150.0K sh | Aug 28, 2026 traded Aug 25, 2026 |
| 23 | Klein FrankChief Operations Officer |  RKLBRocket Lab CorpOpen-market sale · 10b5-1 plan | SELL | $31K 458 sh | Aug 28, 2026 traded Aug 27, 2026 |
| 23 | Scherger Stephen R.Director |  MIDDMIDDLEBY CorpDerivative conversion | C | — 349 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 23 | Shah Tejas P.Director | MIDDMIDDLEBY Corp Derivative conversion | C | — 349 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 23 | Bowerman JulieDirector | MIDDMIDDLEBY Corp Derivative conversion | C | — 349 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 23 | McVeety Kristen JGC and Secretary |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 232 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 23 | Voss Capital, LP10% Owner |  FLYWFlywire CorpOpen-market sale | SELL | $1.74M 91.9K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 22 | Sachetta EricDirector |  SRTSSensus Healthcare, Inc.Open-market purchase | BUY | $35K 10.9K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 22 | Sachetta EricDirector | SRTSSensus Healthcare, Inc. Open-market purchase | BUY | $32K 9,708 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 21 | Abernethy James SDirector |  PEBKPEOPLES BANCORP OF NORTH CAROLINA INCOpen-market sale | SELL | $43K 1,000 sh | Aug 28, 2026 traded Aug 27, 2026 |
| 21 | Ross Andrew DDirector |  SYMSymbotic Inc.Option exercise | M | — 2,568 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 21 | Ungrodt JodiDirector |  BSEMBioStem Technologies, Inc.Option exercise | M | — 5,647 sh | Aug 28, 2026 traded Aug 27, 2026 |
| 21 | Goldman Neal IDirector |  KLNGKoil Energy Solutions, Inc.Open-market sale | SELL | $20K 6,125 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 21 | Streams MarkDirector, See Remarks |  STUBStubHub Holdings, Inc.Open-market sale | SELL | $17K 2,530 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 21 | Harden Sarah PatriciaDirector |  MGNIMAGNITE, INC.Open-market sale · 10b5-1 plan | SELL | $442K 18.4K sh | Aug 28, 2026 traded Aug 28, 2026 |
| 21 | Saxonov SergeDirector, Chief Executive Officer |  TXG10x Genomics, Inc.Open-market sale · 10b5-1 plan | SELL | $415K 6,494 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 21 | Ross Andrew DDirector | SYMSymbotic Inc. Option exercise | M | — 2,568 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 20 | Harden Sarah PatriciaDirector | MGNIMAGNITE, INC. Open-market sale · 10b5-1 plan | SELL | $712K 30.6K sh | Aug 28, 2026 traded Aug 26, 2026 |
| 20 | Voss Capital, LP10% Owner | FLYWFlywire Corp Open-market sale | SELL | $485K 25.5K sh | Aug 28, 2026 traded Aug 26, 2026 |
| 20 | Curran TerrieDirector | ARQTArcutis Biotherapeutics, Inc. Option exercise | M | $84K 11.1K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 20 | Sousa Mauad BrunoDirector |  AUGOAura Minerals Inc.Open-market sale | SELL | $445K 14.9K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 20 | Denbaars StevenDirector |  ALMUAeluma, Inc.Open-market sale | SELL | $173K 12.5K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 19 | Cerwin Brittany CChief Accounting Officer | MIDDMIDDLEBY Corp Derivative conversion | C | — 877 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 19 | Spittle SteveChief Commercial Officer | MIDDMIDDLEBY Corp Derivative conversion | C | — 1,823 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 19 | Pool III James KChief Technology and* | MIDDMIDDLEBY Corp Derivative conversion | C | — 1,823 sh | Aug 28, 2026 traded Jul 20, 2026 |
| 19 | Sterling Michelle MDirector |  APPSDigital Turbine, Inc.Grant or award | A | — 19.0K sh | Aug 28, 2026 traded Aug 25, 2026 |
| 18 | Saxonov SergeDirector, Chief Executive Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $221K 3,500 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 17 | Hamady Robert RamseyChief Financial Officer |  SMRNUSCALE POWER CorpOption exercise | M | — 76.9K sh | Aug 28, 2026 traded Aug 26, 2026 |
| 17 | Suarez Gonzalez SusanaEX. VP & CHIEF HUMAN RESOURCES |  AMCRAmcor plcOption exercise | M | — 4,682 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 17 | Walker Mark DDirector, Chairman and CEO |  DRCTDirect Digital Holdings, Inc.Derivative conversion | C | — 10.0K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 17 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $2.10M 6,517 sh | Aug 28, 2026 traded Aug 10, 2026 |
| 17 | Hyman JonathanChief Technology Officer |  BRZEBraze, Inc.Open-market sale · 10b5-1 plan | SELL | $1.05M 32.7K sh | Aug 28, 2026 traded Aug 27, 2026 |
| 15 | McCarthy Daniel JosephPRESIDENT |  EVHEvolent Health, Inc.Open-market sale · 10b5-1 plan | SELL | $329K 65.9K sh | Aug 28, 2026 traded Aug 26, 2026 |
| 15 | Saxonov SergeDirector, Chief Executive Officer | TXG10x Genomics, Inc. Open-market sale · 10b5-1 plan | SELL | $32K 492 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 14 | Voss Capital, LP10% Owner | FLYWFlywire Corp Open-market sale | SELL | $11K 555 sh | Aug 28, 2026 traded Aug 26, 2026 |
| 14 | Piscitelli DominicChief Financial Officer |  ORICOric Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | $227K 52.0K sh | Aug 28, 2026 traded Aug 26, 2026 |